Partnering with the U.S. Government to Support Biodefense from Detection to Response

Threats to U.S. national health security are becoming more frequent and complex, requiring stronger coordination between government and industry to improve detection capabilities, develop countermeasures, and deliver them at scale. This session will convene senior U.S. government officials, industry leaders, and policy experts to examine how public-private partnerships can be strengthened at each stage of the preparedness lifecycle. Through a series of focused panels, speakers will explore how the U.S. government is strengthening surveillance systems, accelerating innovation, modernizing acquisition pathways, expanding manufacturing capacity, and shaping the policy environment to support a resilient medical countermeasure enterprise. Attendees will gain practical insights into how to engage with key agencies, navigate funding and contracting pathways, and align capabilities with U.S. national security priorities. This discussion will provide a clear, end-to-end view of how government and industry work together to detect, respond to, and mitigate chemical, biological, radiological, nuclear threats, and emerging infectious diseases at speed and scale.